Skip to Main Content
March 12, 2021

Health Law Weekly

HHS Proposes Further Delaying Rule on Insulin, Epinephrine Pricing

  • March 12, 2021

The Department of Health and Human Services (HHS) is proposing to further delay the effective date of a final rule requiring health centers purchasing drugs through the 340B Drug Discount Program to provide low-income patients insulin and injectable epinephrine at the 340B price.

You must be logged in to access this content.